Publicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria de Navarra (46)

2024

  1. Mucus-penetrating and permeation enhancer albumin-based nanoparticles for oral delivery of macromolecules: Application to bevacizumab

    Drug Delivery and Translational Research, Vol. 14, Núm. 5, pp. 1189-1205

  2. Serum Amyloid A as a Potential Biomarker for Disease Activity in Chronic Spontaneous Urticaria

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 12, Núm. 1, pp. 195-200

  3. Targeting and activation of macrophages in leishmaniasis. A focus on iron oxide nanoparticles

    Frontiers in Immunology, Vol. 15

  4. Unveiling the immunomodulatory effect of the novel probiotic Akkermansia muciniphila and its protective effect in vitro

    Microbiological Research, Vol. 283

2023

  1. 3D printing of microencapsulated Lactobacillus rhamnosus for oral delivery

    International Journal of Pharmaceutics, Vol. 641

  2. COVID-19 Publications in Allergy Journals, 2020-2021: A Bibliometric Analysis

    Journal of investigational allergology & clinical immunology, Vol. 33, Núm. 2, pp. 131-133

  3. Comparison of antibacterial activity and cytotoxicity of silver nanoparticles and silver-loaded montmorillonite and saponite

    Applied Clay Science, Vol. 240

  4. Encapsulation of Lactobacillus plantarum in casein-chitosan microparticles facilitates the arrival to the colon and develops an immunomodulatory effect

    Food Hydrocolloids, Vol. 136

  5. Exploring Novel Drug Combinations: The Therapeutic Potential of Selanyl Derivatives for Leishmania Treatment

    Molecules, Vol. 28, Núm. 15

  6. Medical algorithm: Diagnosis and management of histaminergic angioedema

    Allergy: European Journal of Allergy and Clinical Immunology

  7. Next generation of selenocyanate and diselenides with upgraded leishmanicidal activity

    Bioorganic Chemistry, Vol. 138

  8. Preparation of Selenium-Based Drug-Modified Polymeric Ligand-Functionalised Fe3O4 Nanoparticles as Multimodal Drug Carrier and Magnetic Hyperthermia Inductor

    Pharmaceuticals, Vol. 16, Núm. 7

  9. Unveiling chronic spontaneous urticaria pathophysiology through systems biology

    Journal of Allergy and Clinical Immunology, Vol. 151, Núm. 4, pp. 1005-1014

  10. Usefulness of Drug Allergy Alert Systems: Present and Future

    Current Treatment Options in Allergy, Vol. 10, Núm. 4, pp. 413-427

  11. Zein-based nanospheres and nanocapsules for the encapsulation and oral delivery of quercetin

    International Journal of Pharmaceutics, Vol. 643

2022

  1. Angioedema severity and impact on quality of life: Chronic histaminergic angioedema versus chronic spontaneous urticaria

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 10, Núm. 11, pp. 3039-3043.e3

  2. Effect of topical berberine in murine cutaneous leishmaniasis lesions

    Journal of Antimicrobial Chemotherapy, Vol. 77, Núm. 4, pp. 1072-1081

  3. Norbornene and Related Structures as Scaffolds in the Search for New Cancer Treatments

    Pharmaceuticals, Vol. 15, Núm. 12

  4. SARS-CoV-2 vaccine excipients polyethylene glycol and trometamol do not induce mast cell degranulation, in an in vitro model for non-IgE-mediated hypersensitivity

    Frontiers in Allergy, Vol. 3

  5. Unraveling the Diagnosis of Kiwifruit Allergy: Usefulness of Current Diagnostic Tests

    Journal of Investigational Allergology and Clinical Immunology, Vol. 32, Núm. 3, pp. 206-212